<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
    <channel>
        <title>AIDS &amp; HIV</title>
        <link>http://aids.immunodefence.com/</link>
        <description></description>
        <language>en-us</language>
        <copyright>Copyright 2011</copyright>
        <lastBuildDate>Sat, 21 Jul 2007 01:01:48 +0000</lastBuildDate>
        <generator>http://www.sixapart.com/movabletype/</generator>
        <docs>http://www.rssboard.org/rss-specification</docs>
        
        <item>
            <title>HIV vaccine ready for clinical trials</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/clinical_trials2.jpg" border="0" alt="clinical trials" title="clinical trials" hspace="4" vspace="2" align="left" />A vaccine that is capable of delivering a double whammy against AIDS-causing human immunodeficiency virus by both providing immunity against the infection while at the same time destroying cells infected by the virus is ready for clinical trials, a group of Russian researchers announced today.</p> <p>The team from  	Vector State Scientific Center of Virology and Biotechnology, Kol&rsquo;tsovo, Novosibirsk  first <a href="http://www.springerlink.com/content/h0u280742k25306p/">reported </a>their research on the CombiHIVvac in the journal Doklady Biochemistry and Biophysics in May 2007.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/07/hiv-vaccine-ready-for-clinical.html</link>
            <guid>http://aids.immunodefence.com/2007/07/hiv-vaccine-ready-for-clinical.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">AIDS/HIV vaccine</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">combiHIVvac</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">vaccine</category>
            
            <pubDate>Sat, 21 Jul 2007 01:01:48 +0000</pubDate>
        </item>
        
        <item>
            <title>Key Hearing Awaits Pfizer Drug</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/pfizer_logo.gif" border="0" alt="pfizer" title="pfizer" hspace="4" vspace="2" width="160" height="100" align="right" />A panel of outside medical experts is meeting Tuesday to evaluate a Pfizer HIV and AIDS drug that, if approved, would the the first in a new class of treatments.  Pfizer is seeking support from the Food and Drug Administration for maraviroc, a pill being targeted at patients for whom other drugs, or drug combinations, have become ineffective.  </p><p>Maraviroc &quot;could broaden the arsenal of treatments to combat resistant forms&quot; of the virus that causes AIDS, Pfizer told analysts last week when it issued first-quarter results. Maraviroc would be the first new oral class of HIV, or human immunodeficiency virus, medicines in more than 10 years, Pfizer said.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/04/key-hearing-awaits-pfizer-drug.html</link>
            <guid>http://aids.immunodefence.com/2007/04/key-hearing-awaits-pfizer-drug.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV/AIDS Drugs</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">ccr5 coreceptor</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">celsentri</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">FDA</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">gsk</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">hiv drugs</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">maraviroc</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">pfizer</category>
            
            <pubDate>Tue, 24 Apr 2007 15:17:34 +0000</pubDate>
        </item>
        
        <item>
            <title>WHO support male circumcision to fight spread of AIDS</title>
            <description><![CDATA[<img src="http://aids.immunodefence.com/i/circumcision.jpg" border="1" hspace="2" vspace="2" width="113" height="172" align="left" />UN health agencies on Wednesday gave the stamp of approval for including male circumcision in the panoply of arms to fight the spread of AIDS, stressing though that its success also depended on safe-sex awareness, sensitivity and resources. <p>The World Health Organisation (WHO) and the specialised agency UNAIDS declared that millions of lives could be saved if circumcision were widely and safely practised.</p><p>They issued guidelines at a press conference in Paris following a debate among experts, health officials and grassroots groups in Geneva on March 6-8.&nbsp;</p><p>&quot;The recommendations represent a significant step forward in <br />HIV prevention,&quot; said Kevin de Cock, director of the WHO&#39;s HIV/AIDS Department. </p>]]></description>
            <link>http://aids.immunodefence.com/2007/03/who-support-male-circumcision.html</link>
            <guid>http://aids.immunodefence.com/2007/03/who-support-male-circumcision.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV/AIDS Awareness</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">aids</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">awareness</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">circumcision</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
            <pubDate>Thu, 29 Mar 2007 00:52:38 +0000</pubDate>
        </item>
        
        <item>
            <title>German AIDS Action Plan Aims to Revive Awareness</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/german_aids_ads.jpg" border="0" alt="german ad campaign" title="german ad campaign" hspace="4" vspace="2" width="135" height="100" align="right" />The German cabinet approved a national action  plan against the spread of HIV and AIDS, which focuses on increased preventive  measures and research into new strains of drug-resistant viruses. </p> <p>When it comes to HIV and AIDS,  the discrepancy between knowledge of the disease and actual behavior is  widening, German leaders warned this week.</p>  <p>According to government  statistics, almost 100 percent of the German population is aware of the most  frequent modes of HIV transmission and ways to protect against infection. </p>]]></description>
            <link>http://aids.immunodefence.com/2007/03/german-aids-action-plan-aims-t.html</link>
            <guid>http://aids.immunodefence.com/2007/03/german-aids-action-plan-aims-t.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV/AIDS Awareness</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">aids</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">awareness</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">condoms</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">Germany</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">preventing HIV</category>
            
            <pubDate>Thu, 08 Mar 2007 21:03:23 +0000</pubDate>
        </item>
        
        <item>
            <title>Raltegravir Shows Promise in Patients With Drug-Resistant HIV: Presented at CROI</title>
            <description><![CDATA[<img src="http://immunodefence.com/ii/clinical_trials1.jpg" border="0" alt="clinical trials" title="clinical trials" hspace="4" vspace="2" width="100" height="150" align="left" />LOS ANGELES, CA -- March 6, 2007 -- Raltegravir  could be a viable therapeutic option for people with highly drug-resistant  strains of HIV, according to findings from 2 studies presented here at the  14th Conference on Retroviruses and Opportunistic Infections  (CROI).<br /><br />The drug inhibits the enzyme  HIV-1 integrase, making it effective against multi-drug resistant strains of  HIV-1 and particularly CCR5-tropic and CXCR4-tropic strains, said investigator  David Cooper, MD, director, National Centre in HIV Epidemiology and Clinical  Research, University of New South Wales, Sydney, Australia.<br /><br />In a presentation on February 28th, Dr. Cooper  discussed the study -- Blocking integrase in treatment Experienced patients with  a Novel Compound against HIV: MeRcK, MK-0518 (BENCHMRK)-1 -- which included  patients in Europe, Asia/Pacific, and Peru.]]></description>
            <link>http://aids.immunodefence.com/2007/03/raltegravir-shows-promise-in-p.html</link>
            <guid>http://aids.immunodefence.com/2007/03/raltegravir-shows-promise-in-p.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV/AIDS Drugs</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">drug resistance</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">raltegravir</category>
            
            <pubDate>Wed, 07 Mar 2007 12:22:14 +0000</pubDate>
        </item>
        
        <item>
            <title>Half Of HIV Spread By Newly Infected</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/aids_ribbon1.jpg" border="0" alt="aids" title="aids" hspace="4" vspace="2" align="right" />Science Daily &mdash; A new study led by  McGill University researchers shows that half of all HIV transmissions happen  when newly infected people don&rsquo;t know they are carrying the virus and may not  even test positive for it.</p><p>The study, published in the April edition of the Journal of Infectious  Diseases and already available online, followed 2,500 patients in eight Montreal  HIV clinics over eight years. It showed that newly infected patients are eight  times more likely to transmit the virus than those in the chronic stage of AIDS  given the same behaviour.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/03/half-of-hiv-spread-by-newly-in.html</link>
            <guid>http://aids.immunodefence.com/2007/03/half-of-hiv-spread-by-newly-in.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV Infection</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">aids</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">infection risk</category>
            
            <pubDate>Wed, 07 Mar 2007 12:13:10 +0000</pubDate>
        </item>
        
        <item>
            <title>CD4 Count Predicts Non-Opportunistic Diseases in HIV</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/aids_ribbon2.jpg" border="0" alt="AIDS" title="AIDS" hspace="4" vspace="2" width="100" height="123" align="left" />LOS ANGELES, Feb. 28 -- Like the traditional HIV-associated opportunistic infections, the toll of conditions such as heart and liver disease is also affected by the immune status of a patient, researchers reported here.</p><p>Most of us have previously assumed that prolonged survival and advancing age explain much of the increase in these common end-organ diseases&quot; among HIV patients, said Jason Baker, M.D., of the University of Minnesota at the Conference on Retroviruses and Opportunistic Infections here.</p><p>But in fact, he told an oral abstract session, the increase is related to a patient&#39;s CD4 count.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/03/cd4-count-predicts-nonopportun.html</link>
            <guid>http://aids.immunodefence.com/2007/03/cd4-count-predicts-nonopportun.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV Infection</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">aids</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">CD4 cells</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">opportunistic deseases</category>
            
            <pubDate>Thu, 01 Mar 2007 13:40:39 +0000</pubDate>
        </item>
        
        <item>
            <title>Breastfeeding safer for some HIV-infected mothers</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/breastfed.jpg" border="0" alt="breastfed child" title="breastfed child" hspace="4" vspace="2" width="100" height="103" align="right" />Breast-feeding, which helps build a baby&#39;s immune system, may be the best option for HIV-infected mothers in developing countries, despite the risk of transmitting the virus that causes AIDS to their babies, according to new studies presented on Monday.</p> <p>HIV-positive mothers generally are counseled to feed their babies formula to limit the risk of transmission of the human immunodeficiency virus, but that has caused problems in nations where clean water and other needs may not be met.</p> <p>Dr. Hoosen Coovadia a pediatrician at South Africa&#39;s University of KwaZulu-Natal, told the 14th Conference on Retroviruses and Opportunistic Infections that instructing HIV-infected mothers in developing nations to breast-feed would result in about 300,000 children becoming infected with HIV, but would save 1.5 million from dying of other diseases.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/breastfeeding-safer-for-some-h.html</link>
            <guid>http://aids.immunodefence.com/2007/02/breastfeeding-safer-for-some-h.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV Infection</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">Africa</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">breastfeeding</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">immune system</category>
            
            <pubDate>Tue, 27 Feb 2007 14:27:15 +0000</pubDate>
        </item>
        
        <item>
            <title>UN rep expelled after comment on Gambian president&apos;s AIDS cure</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/hiv_aids_africa.gif" border="0" alt="HIV/AIDS" title="HIV/AIDS" hspace="4" vspace="2" width="150" height="158" align="left" />The government of The Gambia gave the most senior United Nations official in the country 48 hours to leave the country starting Friday, following remarks she made criticising Gambian President Yahya Jammeh&rsquo;s widely-publicised cure for HIV/AIDS.</p><p>Dadzai Gwardzimba, UN Resident Coordinator in the capital Banjul, is due to travel to New York, the UN Development Programme (UNDP) said in a statement on Friday afternoon.<br /> <br /> President Jammeh announced he had a cure for AIDS in January. It is reportedly made from herbs and bananas. He said he can eliminate the human immunodeficiency virus (HIV) from people living with the virus and heal people with AIDS in a matter of days. Footage of the president applying his treatment has been widely broadcast on state-run television. </p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/un-rep-expelled-after-comment.html</link>
            <guid>http://aids.immunodefence.com/2007/02/un-rep-expelled-after-comment.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">General HIV/AIDS News</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">advertisment</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">gambia</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">UN</category>
            
            <pubDate>Tue, 27 Feb 2007 14:24:13 +0000</pubDate>
        </item>
        
        <item>
            <title>Russia: $2.9Bln to Go Toward Combating Disease</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/hiv_russia.jpg" border="0" alt="HIV in Russia" title="HIV in Russia" hspace="4" vspace="2" width="130" height="100" align="right" />The Cabinet has tentatively approved a $2.9 billion program aimed at raising the country&#39;s life expectancy by tackling AIDS, diabetes, tuberculosis and other diseases.</p> <p>Health and Social Development Minister Mikhail Zurabov trumpeted the HIV portion of the program as &quot;an essential step forward.&quot; </p> <p>Under the program, the state would provide medical treatment for 30,000 people living with HIV. &quot;A couple years ago, only 700 people with HIV or AIDS could get treatment,&quot; Zurabov told the Cabinet while presenting the five-year program Thursday.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/russia-29bln-to-go-toward-comb.html</link>
            <guid>http://aids.immunodefence.com/2007/02/russia-29bln-to-go-toward-comb.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">General HIV/AIDS News</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">aids</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">fund raising</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">russia</category>
            
            <pubDate>Mon, 26 Feb 2007 16:26:09 +0000</pubDate>
        </item>
        
        <item>
            <title>Herpes treatment may help HIV patients: study</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/valtrex.jpg" border="0" alt="valtrex valacyclovir" title="valtrex valacyclovir" hspace="4" vspace="2" width="100" height="116" align="left" />Treating genital herpes may slow the progression of the AIDS virus in those  infected with both viruses, researchers reported on Wednesday.</p> <p>The test involving 140 women in the West African country of Burkina Faso  found that when herpes was being treated with 500 milligrams of the drug  valacyclovir twice daily for three months, the women were less likely to shed,  or spread, the AIDS virus.</p> <p>In addition, the treatment reduced the levels of AIDS virus in the blood, the  research group led by Dr. Nicolas Nagot of the London School of Hygiene and  Tropical Medicine found.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/herpes-treatment-may-help-hiv.html</link>
            <guid>http://aids.immunodefence.com/2007/02/herpes-treatment-may-help-hiv.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV Treatment</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">canada</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">herpes drug</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">treatment</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">valacyclovir</category>
            
            <pubDate>Thu, 22 Feb 2007 22:31:52 +0000</pubDate>
        </item>
        
        <item>
            <title>3 given organs from HIV-positive donor</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/italy_transplant.jpg" border="0" alt="Carreggi hospital medical director Mauro Marabini, left, and director of transplants organization Franco Filipponi, answer reporters questions during a press conference in Florence, Italy, Tuesday Feb. 20, 2007 after the liver and the kidneys of an HIV positive woman were transplanted to three patients, due to a mistake in the transcription of the blood exams. (AP Photo/Lorenzo Galassi)" title="Carreggi hospital medical director Mauro Marabini, left, and director of transplants organization Franco Filipponi, answer reporters questions during a press conference in Florence, Italy, Tuesday Feb. 20, 2007 after the liver and the kidneys of an HIV positive woman were transplanted to three patients, due to a mistake in the transcription of the blood exams. (AP Photo/Lorenzo Galassi)" hspace="4" vspace="2" align="right" />Three patients at hospitals in Tuscany were mistakenly given organs from an HIV-positive donor, raising serious concerns about transplant procedures in Italy.</p> <p>A 41-year-old woman&#39;s kidneys and liver were taken after she died of a brain hemorrhage at Florence&#39;s Careggi hospital and were implanted due &quot;to a tragic human error,&quot; the hospital said in a statement Monday. The director of the regional transplants agency said the patients&#39; chances of infection are high.</p> <p>The HIV test on the organs had come back positive, but &quot;unfortunately the expert who did the report wrote down &#39;negative&#39; for all the tests, including this one,&quot; said Careggi director Mauro Marabini.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/3-given-organs-from-hivpositiv.html</link>
            <guid>http://aids.immunodefence.com/2007/02/3-given-organs-from-hivpositiv.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">General HIV/AIDS News</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">italy</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">transplants</category>
            
            <pubDate>Wed, 21 Feb 2007 15:49:37 +0000</pubDate>
        </item>
        
        <item>
            <title>Gambia&apos;s leader claims prayer, green paste can cure AIDS</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/aids_ribbon2.jpg" border="0" alt="AIDS" title="AIDS" hspace="4" vspace="2" width="100" height="123" align="left" /> BANJUL, Gambia -- From the pockets of his billowing white robe, Gambia&#39;s president pulls out a plastic container, closes his eyes in prayer and rubs a green herbal paste onto the ribcage of the patient -- a concoction he claims is a cure for AIDS.</p>   <p>  He then orders the thin man to swallow a bitter yellow drink, followed by two bananas.</p><p>  <!-- start sidebar --> &#39;&#39;Whatever you do, there are bound to be skeptics, but I can tell you my method is foolproof,&#39;&#39; President Yahya Jammeh told a reporter. &#39;&#39;Mine is not an argument, mine is a proof. It&#39;s a declaration. I can cure AIDS and I will.&#39;&#39;</p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/gambias-leader-claims-prayer-g.html</link>
            <guid>http://aids.immunodefence.com/2007/02/gambias-leader-claims-prayer-g.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">HIV/AIDS Awareness</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">Africa</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">aids</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">awareness</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">gambia</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">prayer</category>
            
            <pubDate>Wed, 21 Feb 2007 15:45:36 +0000</pubDate>
        </item>
        
        <item>
            <title>South Africa: Aids spending to top R5bn</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/hiv_aids_africa.gif" border="0" alt="HIV/AIDS Africa" title="HIV/AIDS Africa" hspace="4" vspace="2" width="150" height="158" align="right" />SPENDING on dedicated HIV and Aids programmes by national and provincial government departments will exceed R5bn within the next two years, according to today&rsquo;s budget.<!--blurb0--> </p> <p><!--par1--> The Treasury says in its budget review that an additional R1,65bn has been committed to provinces over the next three years for their Aids treatment programmes.<!--par0--></p> <p><!--par1--> The programmes are currently being run at 272 sites, and the health department says over 210,000 patients there are on antiretorviral (ARV) treatment.</p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/south-africa-aids-spending-to.html</link>
            <guid>http://aids.immunodefence.com/2007/02/south-africa-aids-spending-to.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">General HIV/AIDS News</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">aids</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">HIV</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">south africa</category>
            
            <pubDate>Wed, 21 Feb 2007 15:40:28 +0000</pubDate>
        </item>
        
        <item>
            <title>Mobile phones: the new tool to combat AIDS in Africa</title>
            <description><![CDATA[<p><img src="http://immunodefence.com/ii/mobiles_africa.jpg" border="0" alt="nobile phones in africa" title="nobile phones in africa" hspace="4" vspace="2" width="100" height="139" align="left" />Mobile phones will be used to help fight the HIV/AIDS pandemic in Africa, it was announced at the 3GSM World Congress in Barcelona. </p> <p>A public-private partnership between five member groups of the mobile phone industry and the US government has formed the Phones for Health initiative. </p> <p>Phones for Health is a $10m scheme aimed at using mobile phone coverage to strengthen health systems in 10 African countries. </p> <p>Firms working on the project include the GSM Association, the US President&rsquo;s Emergency Plan for AIDS Relief, Accenture, Motorola, MTN and Voxiva. </p>]]></description>
            <link>http://aids.immunodefence.com/2007/02/mobile-phones-the-new-tool-to.html</link>
            <guid>http://aids.immunodefence.com/2007/02/mobile-phones-the-new-tool-to.html</guid>
            
                <category domain="http://www.sixapart.com/ns/types#category">General HIV/AIDS News</category>
            
            
                <category domain="http://www.sixapart.com/ns/types#tag">Africa</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">GSM operators</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">mobile phones</category>
            
                <category domain="http://www.sixapart.com/ns/types#tag">preventing HIV</category>
            
            <pubDate>Tue, 20 Feb 2007 15:18:17 +0000</pubDate>
        </item>
        
    </channel>
</rss>

